Cargando…

Infliximab: A treatment option for multisystem inflammatory syndrome in children with ulcerative colitis?

Detalles Bibliográficos
Autores principales:	Alkan, Gulsum, Emiroglu, Melike, Oz, Sadiye Kubra Tuter, Ergani, Anna Carina, Emiroglu, Halil Haldun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Turkish Pediatric Association 2021
Materias:	Scientific Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8152652/ https://www.ncbi.nlm.nih.gov/pubmed/34104920 http://dx.doi.org/10.5152/TurkArchPediatr.2021.21057

Ejemplares similares

Gastrointestinal and Liver Manifestations in Children with COVID-19 and Their Relationship to Clinical Course
por: Alkan, Gülsüm, et al.
Publicado: (2022)

Evaluation of hematological parameters and inflammatory markers in children with COVID-19
por: Alkan, Gulsum, et al.
Publicado: (2021)

Management of COVID-19 pneumonia in a child with NEMO deficiency
por: Alkan, Gulsum, et al.
Publicado: (2021)

Clinical features and outcome of MIS-C patients: an experience from Central Anatolia
por: Alkan, Gulsum, et al.
Publicado: (2021)

Retinal and choroidal vascular changes in newly diagnosed celiac disease: An optical coherence tomography angiography study
por: Gumus, Meltem, et al.
Publicado: (2022)

Two Different Life-Threatening Cases: Presenting with Torticollis
por: Alkan, Gülsüm, et al.
Publicado: (2016)

DiGeorge Syndrome with Sacral Myelomeningocele and Epilepsy
por: Alkan, Gülsüm, et al.
Publicado: (2017)

Letter regarding “Is liver biopsy essential to identifying the immune tolerant phase of chronic hepatitis B?”
por: Emiroglu, Halil Haldun
Publicado: (2023)

Occult Disseminated Tuberculosis with Holocord Longitudinally Extensive Transverse Myelitis: A Rare Phenomenon in a Child
por: Alkan, Gülsüm, et al.
Publicado: (2017)

Frequency and safety of COVID-19 vaccination in children with multisystem inflammatory syndrome: a telephonic interview-based analysis
por: Aykac, Kubra, et al.
Publicado: (2022)

Infliximab in ulcerative colitis
por: Levin, Avi, et al.
Publicado: (2008)

The Effect of Infliximab on Patients with Ulcerative Colitis in Korea
por: Seo, Hyun Il, et al.
Publicado: (2014)

Pediatric Ulcerative Colitis: The Therapeutic Road to Infliximab
por: Puthoor, Pamela R., et al.
Publicado: (2013)

Acute Appendicitis in Multisystem Inflammatory Syndrome
por: Samprathi, Madhusudan, et al.
Publicado: (2021)

Infliximab: the evidence for its place in therapy in ulcerative colitis
por: Van Assche, Gert, et al.
Publicado: (2007)

Promising effect of infliximab on the extent of involvement in ulcerative colitis
por: Adibi, Peyman, et al.
Publicado: (2011)

Cause for controversy? Infliximab in the treatment of ulcerative colitis: an update
por: Lawlor, Garrett, et al.
Publicado: (2009)

Population pharmacokinetic analysis of infliximab in patients with ulcerative colitis
por: Fasanmade, Adedigbo A., et al.
Publicado: (2009)

Pericardial Effusion due to Infliximab Therapy for Ulcerative Colitis
por: Mirza, Muhammad, et al.
Publicado: (2018)

Early Serum Infliximab Levels in Pediatric Ulcerative Colitis
por: deBruyn, Jennifer C. C., et al.
Publicado: (2021)

The Multisystem Inflammatory Syndrome of Childhood (MIS-C)
por: Sinaei, Reza, et al.
Publicado: (2021)

Atypical Multisystem Inflammatory Syndrome in Children (MIS-C)
por: Acharya, Suchi, et al.
Publicado: (2021)

Cost-utility analysis of infliximab and adalimumab for refractory ulcerative colitis
por: Xie, Feng, et al.
Publicado: (2009)

Autoimmune hemolytic anemia associated with infliximab infusion in ulcerative colitis
por: Mir, Fazia A., et al.
Publicado: (2018)

Listeria Meningitis during Infliximab-based Treatment for Ulcerative Colitis
por: Tsuchiya, Atsunori, et al.
Publicado: (2018)

Infliximab versus Adalimumab, Which One Is Better for Ulcerative Colitis?
por: Kim, Eun Soo
Publicado: (2021)

Vedolizumab is superior to infliximab in biologic naïve patients with ulcerative colitis
por: Sablich, Renato, et al.
Publicado: (2023)

Therapeutic Drug Monitoring of Infliximab in Acute Severe Ulcerative Colitis
por: Gordon, Benjamin L., et al.
Publicado: (2023)

Multisystem Inflammatory Syndrome in Children: A Mimicker of Severe Dengue
por: Samprathi, Madhusudan, et al.
Publicado: (2020)

SARS-CoV-2 infection as trigger multisystem inflammatory syndrome?()
por: Fernández-González, Sara M., et al.
Publicado: (2021)

Multisystem inflammatory syndrome in adults associated to SARS-CoV-2()()
por: Llenas-García, Jara, et al.
Publicado: (2022)

Four Cases of Papilledema in COVID-19 Multisystem Inflammatory Syndrome in Children
por: Rostamian, Mosayeb, et al.
Publicado: (2022)

Pediatric ulcerative colitis: current treatment approaches including role of infliximab
por: Bradley, Gia M, et al.
Publicado: (2012)

Cost-Effectiveness of Infliximab for the Treatment of Acute Exacerbations of Ulcerative Colitis in the Netherlands
por: Chaudhary, Mohammad A., et al.
Publicado: (2012)

Linear IgA dermatosis after infliximab infusion for ulcerative colitis
por: Bryant, Kelli D., et al.
Publicado: (2016)

An indirect comparison of infliximab versus adalimumab or golimumab for active ulcerative colitis
por: Kawalec, Paweł, et al.
Publicado: (2016)

Neutrophil-to-Lymphocyte Ratio for Predicting Loss of Response to Infliximab in Ulcerative Colitis
por: Nishida, Yu, et al.
Publicado: (2017)

Disseminated Nocardiosis Associated with Treatment with Infliximab in a Patient with Ulcerative Colitis
por: Garner, Orlando, et al.
Publicado: (2017)

Pooled analysis of the comparative efficacy between tacrolimus and infliximab for ulcerative colitis
por: Liu, Yi-Juan, et al.
Publicado: (2018)

Sarcoidosis associated with infliximab therapy in ulcerative colitis: A case report
por: Gîlcă, Georgiana-Emmanuela, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_o3ksgk5u5rqf3d37hvn0mf3n9d